Arphra AIPlain-English read on Vertex Pharmaceuticals Incorporated’s valuation
Valuation read
Valuation snapshot
Each multiple is placed against its own 5-year range (the dot is the historical percentile of today’s value) and the peer-set sector median. key_metrics_ttm
Multiples · current vs 5-year range vs sector
marker = today’s percentile · sector = peer median
Metric
Current
5-year range
%ile
Sector
Read
P / E (TTM)
—
—
—
—
—
PEG
—
—
—
—
—
EV / EBITDA
—
—
—
—
—
EV / Sales
8.9×
8.7
9.0
60
3.0×
premium to sector
P / S
—
—
—
—
—
P / B
—
—
—
—
—
EV / FCF
29.5×
28.9
33.4
40
18.0×
premium to sector
FCF yield
3.29%
3.0
3.4
80
6.31%
rich vs its history
Relative valuation · vs peers
Healthcare10 peers
Screens expensive vs peersholddecile 7Percentile = rank within the peer cohort; higher is better (cheaper multiples, stronger factor, more upside).